These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29047309)

  • 21. Adenoviruses as vectors for delivering vaccines to mucosal surfaces.
    Babiuk LA; Tikoo SK
    J Biotechnol; 2000 Sep; 83(1-2):105-13. PubMed ID: 11000466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonhuman Adenoviral Vector-Based Platforms and Their Utility in Designing Next Generation of Vaccines for Infectious Diseases.
    Alhashimi M; Elkashif A; Sayedahmed EE; Mittal SK
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amplified and persistent immune responses generated by single-cycle replicating adenovirus vaccines.
    Crosby CM; Nehete P; Sastry KJ; Barry MA
    J Virol; 2015 Jan; 89(1):669-75. PubMed ID: 25355873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid Cloning of Novel Rhesus Adenoviral Vaccine Vectors.
    Abbink P; Kirilova M; Boyd M; Mercado N; Li Z; Nityanandam R; Nanayakkara O; Peterson R; Larocca RA; Aid M; Tartaglia L; Mutetwa T; Blass E; Jetton D; Maxfield LF; Borducchi EN; Badamchi-Zadeh A; Handley S; Zhao G; Virgin HW; Havenga MJ; Barouch DH
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29298888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The potential of adenoviral vaccine vectors with altered antigen presentation capabilities.
    Neukirch L; Fougeroux C; Andersson AC; Holst PJ
    Expert Rev Vaccines; 2020 Jan; 19(1):25-41. PubMed ID: 31889453
    [No Abstract]   [Full Text] [Related]  

  • 26. Adenoviruses as gene/vaccine delivery vectors: promises and pitfalls.
    Appaiahgari MB; Vrati S
    Expert Opin Biol Ther; 2015 Mar; 15(3):337-51. PubMed ID: 25529044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenoviruses as vaccine vectors.
    Tatsis N; Ertl HC
    Mol Ther; 2004 Oct; 10(4):616-29. PubMed ID: 15451446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chimpanzee Adenovirus Vector Ebola Vaccine--Preliminary Report.
    Zhang Q; Seto D
    N Engl J Med; 2015 Aug; 373(8):775-6. PubMed ID: 26287858
    [No Abstract]   [Full Text] [Related]  

  • 29. Engineered adenovirus serotypes for overcoming anti-vector immunity.
    Dharmapuri S; Peruzzi D; Aurisicchio L
    Expert Opin Biol Ther; 2009 Oct; 9(10):1279-87. PubMed ID: 19645630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B.
    Dai G; Rady HF; Huang W; Shellito JE; Mason C; Ramsay AJ
    Vaccine; 2016 Dec; 34(50):6267-6275. PubMed ID: 27823900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Future Prospects for the Development of Cost-Effective Adenovirus Vaccines.
    Fougeroux C; Holst PJ
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28420073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of HIV-1 envelope cytoplasmic tail on adenovirus primed virus encoded virus-like particle immunizations.
    Andersson AC; Ragonnaud E; Seaton KE; Sawant S; Folgori A; Colloca S; Labranche C; Montefiori DC; Tomaras GD; Holst PJ
    Vaccine; 2016 Oct; 34(44):5344-5351. PubMed ID: 27633665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species.
    Colloca S; Barnes E; Folgori A; Ammendola V; Capone S; Cirillo A; Siani L; Naddeo M; Grazioli F; Esposito ML; Ambrosio M; Sparacino A; Bartiromo M; Meola A; Smith K; Kurioka A; O'Hara GA; Ewer KJ; Anagnostou N; Bliss C; Hill AV; Traboni C; Klenerman P; Cortese R; Nicosia A
    Sci Transl Med; 2012 Jan; 4(115):115ra2. PubMed ID: 22218691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chimpanzee adenovirus vector-based avian influenza vaccine completely protects mice against lethal challenge of H5N1.
    Cheng T; Wang X; Song Y; Tang X; Zhang C; Zhang H; Jin X; Zhou D
    Vaccine; 2016 Sep; 34(41):4875-4883. PubMed ID: 27576071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Good manufacturing practice production of adenoviral vectors for clinical trials.
    Lusky M
    Hum Gene Ther; 2005 Mar; 16(3):281-91. PubMed ID: 15812223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early life vaccination: Generation of adult-quality memory CD8+ T cells in infant mice using non-replicating adenoviral vectors.
    Nazerai L; Bassi MR; Uddback IE; Holst PJ; Christensen JP; Thomsen AR
    Sci Rep; 2016 Dec; 6():38666. PubMed ID: 27929135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progress on adenovirus-vectored universal influenza vaccines.
    Xiang K; Ying G; Yan Z; Shanshan Y; Lei Z; Hongjun L; Maosheng S
    Hum Vaccin Immunother; 2015; 11(5):1209-22. PubMed ID: 25876176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenoviruses as vectors for HIV vaccines.
    Gómez-Román VR; Robert-Guroff M
    AIDS Rev; 2003; 5(3):178-85. PubMed ID: 14598567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Process optimization and scale-up for production of rabies vaccine live adenovirus vector (AdRG1.3).
    Shen CF; Lanthier S; Jacob D; Montes J; Beath A; Beresford A; Kamen A
    Vaccine; 2012 Jan; 30(2):300-6. PubMed ID: 22079076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lactococcus lactis-based vaccines from laboratory bench to human use: an overview.
    Bahey-El-Din M
    Vaccine; 2012 Jan; 30(4):685-90. PubMed ID: 22154771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.